Zhejiang Taimei Medical Technology Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong
5 insiders bought shares over the last 90 days, the latest by LU Yiming, filed 16 Sept 2026.
Zhejiang Taimei Medical Technology Co., Ltd. - H Shares: what insiders have been doing
Every trade that managers of Zhejiang Taimei Medical Technology Co., Ltd. - H Shares disclose to HKEX is tracked on this page. The last twelve months, up to 22 October 2026, brought 5 filings signed by 5 insiders.
No insider sold shares on the market over the period. Instead, the filings list 5 purchases, made by 5 insiders. No amount is published for 5 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 5 senior executives.
Compared with its exchange (1,314 companies, median 4 filings), a count of 5 filings is above the norm. Our records for Zhejiang Taimei Medical Technology Co., Ltd. - H Shares go back to 2026, with 5 purchases and no sales on the open market in total.
The clock since the last published purchase (16 September 2026) now reads 53 days. Filings reach the HKEX feed a median of 6 days after the trade. That lag is the time during which only the insider knows about the trade.
Source: insider filings from HKEX. Past trades are no guide to future returns.
Who traded when
BuySaleFinancial data
· cache
- 111,282 sharesShareXHKGHKEX:DA20260915E00534Canonical exit: 9 Dec 2026 (T+90)
- 174,848 sharesShareXHKGHKEX:DA20260915E00529Canonical exit: 9 Dec 2026 (T+90)
- 354,521 sharesShareXHKGHKEX:DA20260915E00518Canonical exit: 9 Dec 2026 (T+90)
- 139,103 sharesShareXHKGHKEX:DA20260915E00565Canonical exit: 9 Dec 2026 (T+90)
- 112,942 sharesShareXHKGHKEX:DA20260915E00541Canonical exit: 9 Dec 2026 (T+90)
5 of 5 declarations
About Zhejiang Taimei Medical Technology Co., Ltd. - H Shares
Zhejiang Taimei Medical Technology Co., Ltd. is a company focused on the development and manufacturing of medical devices. It is listed on the H-share market.